AAPM Task Group 108: PET and PET/CT shielding requirements.
暂无分享,去创建一个
Mark T Madsen | Richard E Wendt | James R Halama | J. Votaw | Jon A. Anderson | R. Wendt | D. Simpkin | M. Madsen | L. Williams | John R Votaw | Jon A Anderson | Michael V Yester | Jeff Kleck | Douglas J Simpkin | Lawrence E Williams | J. Halama | M. Yester | J. Kleck
[1] Christian Vanhove,et al. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[2] Fawcett,et al. Occupational Exposure in Nuclear Medicine and PET. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[3] N L McElroy,et al. Worker dose analysis based on real time dosimetry. , 1998, Health physics.
[4] P. Alagona,et al. Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography , 1994, The International Journal of Cardiac Imaging.
[5] J S Karp,et al. Design considerations for PET scanners. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[6] S C Bushong,et al. Diagnostic X-ray shielding design based on an empirical model of photon attenuation. , 1983, Health physics.
[7] D J Simpkin,et al. Shielding requirements for constant-potential diagnostic x-ray beams determined by a Monte Carlo calculation. , 1989, Health physics.
[8] D Christman,et al. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] R. Marchesini,et al. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose , 1997, European Journal of Nuclear Medicine.
[10] Michael D Harpen. Positronium: review of symmetry, conserved quantities and decay for the radiological physicist. , 2004, Medical physics.
[11] A Bixler,et al. Practical aspects of radiation safety for using fluorine-18. , 1999, Journal of nuclear medicine technology.
[12] M. O'Doherty,et al. Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas. , 2000, European journal of nuclear medicine.
[13] J C Courtney,et al. Photon shielding for a positron emission tomography suite. , 2001, Health physics.
[14] J. Machac,et al. Pet myocardial perfusion and glucose metabolism imaging: Part 2-guidelines for interpretation and reporting , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[15] Paul K. Marsden,et al. Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies? , 1999, European Journal of Nuclear Medicine.
[16] V A McCormick,et al. Radiation dose to positron emission tomography technologists during quantitative versus qualitative studies. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Jeroen J. Bax,et al. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[18] Brian M Methé,et al. Shielding Design for a PET Imaging Suite: A Case Study , 2003, Health physics.
[19] Benjamin W Zeff,et al. Patient self-attenuation and technologist dose in positron emission tomography. , 2005, Medical physics.
[20] T. Berthold,et al. Radiation exposure to sonographers from fluorine-18-FDG PET patients. , 2000, Journal of nuclear medicine technology.
[21] Thea M Lundberg,et al. Measuring and minimizing the radiation dose to nuclear medicine technologists. , 2002, Journal of nuclear medicine technology.
[22] K. Kearfott,et al. Radiation protection design for a clinical positron emission tomography imaging suite. , 1992, Health physics.
[23] F H Fahey,et al. Positron emission tomography instrumentation. , 2001, Radiologic clinics of North America.
[24] W B Tindale,et al. Dose rate measurements from radiopharmaceuticals: implications for nuclear medicine staff and for children with radioactive parents. , 1999, Nuclear medicine communications.
[25] N J Yasillo,et al. Radiation safety considerations for PET centers. , 1997, Journal of nuclear medicine technology.
[26] M. A. Smith,et al. The impact of PET scanning on management of paediatric oncology patients , 2004, European Journal of Nuclear Medicine and Molecular Imaging.